In fact, the precision diagnostics applied at the CFTR gene level made the recent advent of CF precision therapy possible, which, in turn, requires a full assessment of the molecular mechanism(s) of CFTR pathogenic variants [15,16,17]. This evidence concerns the gene CFTR and cystic fibrosis.